Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin’s lymphoma: a phase II, non-randomiz...

por Hochberg, Jessica, Basso, Jaclyn, Shi, Qiuhu, Klejmont, Liana, Flower, Allyson, Bortfeld, Kristina, Harrison, Lauren, van de Ven, Carmella, Moorthy, Chitti, Islam, Humayun, Gerard, Perry, Voss, Stephan, Cairo, Mitchell S
Publicado 2022